Beyond BRCA1/2: polygenic, ‘polyfunctional’ molecular circuitry model to predict breast cancer risk

Author： Lianos Georgios D   Zoras Odysseas   Roukos Dimitrios H  

Publisher： Future Medicine

ISSN： 1752-0363

Source： Biomarkers in Medicine, Vol.7, Iss.5, 2013-10, pp. : 675-678

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BRCA1 and BRCA2 Molecular Testing in Women with Different Risk of Hereditary Breast Cancer: ost/Effectiveness and Psychological Implications

By  

Current Women's Health Reviews, Vol. 8, Iss. 1, 2012-02 ,pp. : 12-16

Bentham Science Publishers

Access to resources Recommend Favorite

Skin cancer risk in BRCA1/2 mutation carriers

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 6, 2015-06 ,pp. : 1498-1506

John Wiley & Sons Inc

Access to resources Recommend Favorite

Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population‐based study

By  

CANCER, Vol. 119, Iss. 20, 2013-10 ,pp. : 3596-3603

John Wiley & Sons Inc

Access to resources Recommend Favorite

Unexpectedly low frequency of BRCA1/2 deleterious mutations in Japanese patients with breast cancer

By  

THE BREAST JOURNAL, Vol. 24, Iss. 1, 2018-01 ,pp. : 96-98

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacological Approaches for BRCA1/2 Related Breast and Ovarian Cancer: Preclinical Studies and Early Clinical Trials

By  

Current Women's Health Reviews, Vol. 8, Iss. 1, 2012-02 ,pp. : 104-110

Bentham Science Publishers

Access to resources Recommend Favorite